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Summary 
Dendritic cells are a small subset of human blood mononuclear cells that are potent stimulators 
of several T cell functions. Here we show they are 10-50-fold more potent than monocytes or 
B cells in inducing T  cell responses to a pand of superantigens. Furthermore, dendritic calls 
can present femtomolar concentrations of superantigen to T calls even at numbers where other 
antigen-presenting calls (APCs) are inactive.  Although dendritic cells express very high levels 
of the major histocompatibility complex products that are required to present superantigens, 
it is only necessary to pulse these APCs for 1 hour with picomolar levels of one superantigen, 
staphylococcal enterotoxin 13, to maximally activate T cells. Our results suggest that very small 
amounts of superantigen will be immunogenic in vivo if presented on dendritic calls. 
M 
' icrobial superantigens are of major clinical interest be- 
L  cause they cause a spectrum of disease in both humans 
and animals. For example, in humans, proteins derived from 
Staphylococcus aureus induce gastroenteritis, toxic shock syn- 
drome, and the scalded skin syndrome (1, 2). In rodents, the 
only species of Mycoplasma known to produce a superantigen, 
M~,coplasma arthritidis, causes a chronic inflammatory polyar- 
thritis  (3,  4). 
Superantigens share several important features that distin- 
guish them from conventional antigens. Superantigens are 
potent mitogens for both human and mouse T cells because 
they typically stimulate large numbers of T cells bearing par- 
ticular TCR V~ gene products (5,  6).  T  cell responses to 
superantigens are not MHC restricted in the classical sense 
since the superantigen is bound and presented by a variety 
of allelic and isotypic MHC molecules (7). Superantigens ap- 
pear to bind to sites on MHC class II molecules that are lo- 
cated outside the peptide binding groove (8, 9).  Where it 
has been studied, binding to MHC class II antigens is half- 
maximal at nanomolar to micromolar levels of superantigen 
(10-12). 
Despite the considerable information available regarding 
binding of superantigens to MHC molecules, there is little 
known comparing the presenting function of different types 
of MHC class II + cells, particularly dendritic cells. We have 
compared the capacity of blood dendritic cells with B cells 
and monocytes to present staphylococcal toxins and M. at- 
thritidis mitogen (MAM) t to human T  cells.  We find that 
dendritic cells are 10-50-fold more e~cient than other APCs 
and require only trace levels of superantigen to initiate T cell 
responses. 
Materials and Methods 
Culture Medium.  RPMI 1640 (Gibco Laboratories, Grand Is- 
land, NY) supplemented with 5% human serum, and 50 #g/ml 
gentamycin was used. 
Mitogens.  Staphylococcal  enterotoxins (SEs) A, 13, and E, and 
toxic shock syndrome toxin 1 (TSST-1) were purchased from Toxin 
Technology (Madison, WI). The mitogens were aliquoted to 10 
~tg/ml in ILPMI and stored at -20 ~ until use. The mitogen MAM, 
a culture supernatant of M. ankritidis, was used at a dilution of 
1:4,000. 
Preparation  of  Lymphoid Cells.  Lymphoid  cells  were isolated  from 
buffy coats obtained from the New York Blood Center and sepa- 
rated into T cell-enriched (erytMocyte rosette-positive [ER*]) and 
T cell-depleted (ER-) fractions by rosetting with neuraminidase- 
treated SRBC. 
T Cells.  The ER § cells were then depleted of non-T cells by 
panning on human Ig-coated plastic dishes (13) and by panning 
1  Abbreviations used in this paler:  ER, erythrocyte rosette; MAM, Myco- 
plasma artkn'tidis mitogen; SE, Staphylococcal enterotoxin; TSST-1, toxic 
shock syndrome toxin 1. 
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ture Collection, RockviUe, MD). The resulting T cell preparations 
failed to proliferate to optimal doses of superantigens  indicating 
negligible  contamination with APCs. 
Monoo/tes.  The ER- fraction was adhered to plastic dishes for 
60-90 rain and nonadherent cells were removed with four to five 
washes. Firmly adherent monocytes were collected by incubating 
the dishes with cold PBS for 15-20 rain and gentle aspiration. Al- 
ternatively,  the adherent cells were cultured with fresh medium 
overnight, at which time the cells were easily dislodged from the 
plastic  surfaces. 
B  Cells and  Dendritic Cells.  Nonadherent  ER-  cells were 
depleted of residual monocytes by panning on Ig-coated plates and 
then layered onto 14.5%  metrizamide (13). After sedimentation 
at 650 g for 10 min at room temperature,  B cells and a few NK 
ceils "pellet" as the high density fraction, while dendritic cells float 
as the low density fraction (13). The cell fractions were washed 
in successively less hypertonic washes before being tested. 
Cell Sorting.  In some experiments,  the APC populations were 
purified further by cell sorting on a FACStar Plus  |  (Becton Dick- 
inson & Co., Mountain View, CA),  10' cells were stained with 
a cocktail of PE-conjugated mAb (10 #1 of stock-purchased mAb 
in 1 ml of medium) on ice for 45 rain, washed three times,  and 
sorted (13). B cells were collected as small Leu-4-, Leu-11-, Leu-19-, 
Leu-M3-negative  cells; dendritic cells were large Leu-4-, Leu-11-, 
Leu-12-, Leu-16-, Leu-19-, Leu-M3-negative cells; and monocytes 
were large Leu-4-, Leu-11-, Leu-12-, Leu-16-, Leu-19-negative cells. 
The sorted cells were analyzed for purity by staining with PE- 
conjugated mAb to B cells (Leu-12 and -16), monocytes (Leu-M3), 
or with a cocktail (Leu-4-CD3, Leu-12-CD19, Leu-16-CD20, Leu- 
19-C016, Leu-M3-CD14; Becton Dickinson & Co.). This verified 
that our populations were >95%  pure. 
Lymphocyte Proliferaaon Assays.  Responses to microbial antigens 
were induced by adding graded doses of viable irradiated  (3,000 
rad 137 Cs) APCs to 1.5  x  105 syngeneic T cells in 96-well flat- 
bottomed plates (Costar, Cambridge, MA) in 0.2 ml of medium. 
In some experiments,  APCs were not irradiated. Proliferation was 
measured by the addition of 4/~Ci/ml [3H]thymidine  (6.0 Ci/ 
raM) for 16 h on day 2 or 3 of culture. For primary MLRs, al- 
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logeneic T ceils were used. [3H]Thymidine was added from 120- 
136 h. Results are expressed in counts per minute as an average 
of triplicates. For pulsing studies, either T cells or APC were in- 
cubated with microbial  antigens for 1 h at 37~  washed three 
times, and added to microtiter wells as above. The cells were pulsed 
at 1-2  x  106/ml in sterile 1.5-ml microcentrifuge polypropylene 
tubes with doses of SEB that ranged from 10 pg/ml to 1 #g/ml. 
Results 
Dendritic Cells Are Potent APCs for a Panel of Microbial Su- 
perantigens.  Blood monocytes, B cells, and dendritic ceils were 
compared for their ability to present the staphylococcal pro- 
teins SEA, SEE, SEB, TSST-1, and the mitogen MAM. When 
present at 1 cell per 30-300 T  cells, dendritic cells were far 
more efficient at stimulating T cell proliferation than mono- 
cytes or B cells (Fig.  1; representative of five experiments). 
At doses of 5-10 ng/ml, maximal T  cell proliferation to the 
staphylococcal toxins was observed at days 2-3  of culture. 
The T  cell proliferative response to M.AM was considerably 
slower, reaching maximal levels at days 4-5.  For this super- 
antigen, monocytes and B cells were strikingly less e~cient 
than dendritic cells (Fig.  1 B). 
In the presence of superantigens, dendritic cells appeared 
to engage T cells in clusters or aggregates as described previ- 
ously for other T  cell responses; e.g., the MLR (14).  The 
superiority of dendritic cells to other APCs could not be ac- 
counted for by time course differences since pulsing cultures 
at later intervals showed similar differences between these cells 
(data not shown). In the allogeneic MLR, dendritic cells are 
the most potent APC when compared with other cells (14). 
A corresponding allogeneic MLR (Fig. 1 A) with the same 
populations of APCs is shown for comparison. 
Trace Numbers of  Purified Dendritic Cells Induce T Cell Mito- 
genesis to Suyerantigens.  We sorted our dendritic cell popu- 
lations to be sure that contaminating cells, e.g., B cell blasts, 
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￿9  B  cells  Figure 1.  Presentation of superantigens to T cells by 
enriched  populations  of  APCs. Graded  doses of AIK2s  (den- 
dritic cells, B cells, monocytes)  were added to T cells (1.5 
x  10  s) in the presence of SEB or SEA (5 ng/ml), TSST-1 
(10 ng/ml), and MAM (1:4,000). T cell proliferation  is 
measured as [3H]TdR incorporation in cpm (average of 
triplicates). Activity of the APC populations in an alIo- 
MLR is shown for comparison. 
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Figure 2.  Purified  dendritic  cells  are the most 
potent APCs for superantigens. APCs were 
purified  by sorting  on a FACStar  ~ as described 
(Materials and Methods) and added at graded 
doses to T cells  with a pand of superantigens. 
were not responsible for the efficient superantigen presenta- 
tion. When compared with sorted B cells and monocyte prepa- 
rations, dendritic cells were consistently 10-50-fold more po- 
tent in presenting TSST-1 (10 ng/ml) and SEB (5 ng/ml; Fig. 
2, A  and B). Similar observations were made with SEE (0.5 
ng/ml; Fig. 2 C). An important finding was that sorted den- 
dritic cells were effective even when present at 1 cell per 3,000 
T  cells. At these doses, dendritic cells did not stimulate al- 
logeneic T cells in the MLK (data not shown). Thus, den- 
dritic cells can present superantigens at concentrations where 
other T cell-dependent responses  are not apparent in vitro. 
These experiments also consistently showed that B cells were 
less potent than monocytes in presenting superantigens.  With 
TSST-1, especially,  B cells were poorly stimulatory. 
Femtomolar Concentrations of Staphylococcal Enterotoxins Can 
Be  E~ciently  Presented by Dendritic  Cells.  The  ability of 
different APCs to stimulate T cells in the presence of a wide 
range of enterotoxin concentrations was evaluated (Table 1). 
At picomolar to femtomolar concentrations of SEE, dendritic 
cells induced T cell proliferation even when present in lim- 
iting numbers (1:300). In fact, the data suggest that dendritic 
cells would be effective at doses of SEE <5 pg/ml (170 fM). 
Monocytes and B cells stimulated T cells at femtomolar con- 
centrations of SEE, but were less eflficient, and relatively high 
stimulator to responder ratios (1:10-30)  were required. 
Expression of MHC  Class  II Antigens  by  Human  Blood 
APCs.  Superantigens bind to MHC class II molecules on 
APCs (11, 12, 15, 16). It was therefore of interest to compare 
Table  1.  Comparison of Different APCs with Low Concentrations of Superantigen 
T cell proliferation in presence of SEE 
APC/T 
APC  cell ratio  5 ng/ml  500 pg/ml  50 pg/ml  5 pg/ml 
cpm  ￿  10 -3 
Monocytes  1:10  359,367  274,793  160,196  67,733 
1:30  183,170  126,238  44,294  14,293 
1:100  68,508  35,527  11,566  4,085 
1:300  23,997  13,843  2,926  601 
B cells  1:10  224,984  148,001  71,166  31,315 
1:30  116,143  60,328  32,574  10,527 
1:100  33,861  14,259  6,183  1,351 
1:300  10,333  1,929  536  275 
DC  1:10  379,401  323,158  330,666  274,365 
1"30  357,553  308,461  260,571  190,876 
1:100  274,187  212,873  163,697  105,577 
1:300  108,316  91,978  66,717  36,971 
5ng/ml (170 pM) to 5 pg/ml (170 fM) concentrations  of SEE were added to graded doses of APC and T cells (1.5  x  10s). T cell proliferation 
is measured as [3H]TdK incorporation in cpm (average of triplicates). 
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APCs (monocytes, B cells, dendritic cells).  A representative 
experiment of three similar results is shown in Fig. 3. Mono- 
cytes, obtained from EK-  cells by plastic adherence,  were 
>90%  pure as judged by staining  with mAb to CD14.  B 
cells and dendritic cells were derived from ER-, FcR- cells 
after layering on metrizamide  gradients.  The  high-density 
fraction was primarily CD19/20 + B cells.  The low-density 
fraction  was 30-80%  dendritic  cells;  i.e.,  large irregularly 
shaped cells that stained brightly with mAbs to class II MHC 
products (HLA-DR, -DO~ and -DP) but not with a cocktail 
of mAb to monocytes (CD14), NK cells (CD16, CD56), B 
cells (CD19, CD20), or T cells (CD3). Compared with the 
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Figure 3.  Ia antigen expression  on enriched monocytes,  B cells (pellet), 
and dendritic cells. APC populations were stained with a panel of mAbs 
(see Results) and analyzed for purity and Ia antigen expression. A repre- 
sentative experiment is shown. Monocytes (CD14  §  were >90% pure. 
The pellet fraction consisted of mostly B cells (CD19/20  +  , 80%), while 
dendritic cells  were >70% pure. Note that the expression  of DR antigens 
for dendritic cells is off scale (third column, sixth row). 
fold more DR, DP, or DQ molecules, as detected by inten- 
sity of staining  (Fig.  3, bottom three panels). 
Superantigen Binding Activity of Dendritic Cells.  The above 
results suggest that dendritic cells are more efficient at pre- 
senting superantigens because of their higher expression of Ia 
antigens. To gain a sense of the degree of occupancy of class 
II, we did pulsing experiments with graded doses of SEB. 
Dendritic cells and B cells were pulsed with femtomolar to 
nanomolar concentrations of SEB for 1 h at 37~  washed 
extensively, and added in graded doses to purified T  cells. 
An additional group of APCs (nonpulsed) were directly added 
in the continuous presence of T  cells  and SEB. At stimu- 
lator/responder ratios of 1:100, maximal T  cell stimulation 
was achieved at 10-100 ng/ml for nonpulsed and pulsed cells 
(Table 2). Half-maximal stimulation was seen when dendritic 
cells were pulsed at  1 ng/ml  (pM) of SEB. Dendritic cells 
pulsed with even femtomolar (10 pg/ml) concentrations of 
superantigen stimulated T cells to proliferate. Published data 
show that the Kd for SEB is 10 -6 (11). Therefore, our results 
suggest that only small amounts of superantigen are needed 
on dendritic cells to maximally stimulate T cells. In contrast 
to dendritic cells,  SEB-pulsed B cells  failed to stimulate T 
cells  even at  stimulator/responder  ratios  of 1:30  (data  not 
shown). 
Discussion 
Antigen presentation by MHC products on dendritic cells 
has been studied in the allogeneic MLR (14), and in responses 
to nominal  antigen  (17) or self-MHC (18).  In all of these 
systems, dendritic cells are effective at very low numbers, e.g., 
at stimulator/responder ratios of 1:100. Other APCs are con- 
siderably less effective or are required at considerably higher 
numbers.  Here we show that dendritic cells are also potent 
APCs for several superantigens.  They are  10-50-fold more 
effective than monocytes or B cells,  and very low numbers 
of dendritic cells (stimulator/responder ratios of 1:3,000) are 
effective.  At  these  trace  numbers,  dendritic  cells  are  not 
stimulatory in the allogeneic MLR. Our data confirm that 
femtomolar concentrations of superantigen are sufficient to 
stimulate T cells (15, 19). In general, previous studies evalu- 
ating superantigen  presentation  by APCs have used B cell 
lines, B cells, monocytes, or Ia-transfected fibroblasts (5, 16, 
19-22). In most cases, however, it has been necessary to use 
these APCs at high stimulator/responder ratios (generally from 
1:100  to  1:2.5)  to elicit responses from T  cells. 
Dendritic cells were consistently better than  monocytes 
or B cells in presenting staphylococcal toxins and MAM. With 
MAM,  however,  we noted even greater  differences in  the 
efficiency of presentation relative to monocytes and B cells 
(Fig. 2 B). It is possible that MAM is presented differently 
by dendritic  cells  than  other  superantigens.  Alternatively, 
MAM may bind with variable efficiency to different class II 
MHC isotypes (e.g., DQ or DP) that  are preferentially ex- 
pressed on dendritic  cells  (Fig.  3). 
The efficiency with which dendritic cells present superan- 
tigen to T  cells is consistent with the degree of Ia antigen 
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T  cell proliferation  in response to SEB 
APC/T cell 
Exp.  APC  ratio  1 /~g/ml  100 ng/ml  10 ng/ml  1 ng/ml  100 pg/ml  10 pg/ml 
cpm  ￿  10 -3 
DC,  1:100  72,024  105,297  106,942  92,923  84,799  69,903 
nonpulsed  1:300  59,137  54,829  56,426  45,937  54,288  44,430 







1:100  141,994  147,489  110,475  52,824  26,375  30,095 
1:300  74,837  67,289  44,411  18,660  8,196  4,073 
1:1,000  44,971  29,179  10,446  3,474  717  505 
1:100  98,935  95,496  79,312  61,043  59,168 
1: 300  54,743  41,666  37,746  28,403  25,769 
1:1,000  23,389  20,690  14,604  7,372  8,945 
1:100  107,619  83,579  66,737  61,694  38,776 
1:300  38,506  33,191  24,811  23,073  8,792 
1:1,000  16,347  13,981  9,546  7,456  2,001 
Dendritic cells were pulsed with varying doses of SEB, 1/~g/ml (35 nM) to 10 pg/ml (350 fM), for 1 h at 37~  washed, and then added in graded 
doses to T cells. Nonpulsed dendritic cells were added directly to T cells after which SEB was aliquoted in the same concentrations as above. T 
cell proliferation is measured as [3H]TdR incorporation in cpm (average of triplicates). For cultures containing nonpulsed dendritic cells, background 
proliferation counts of T cells alone plus SEB have been subtracted from each value. [3H]TdR incorporation of pulsed dendritic cells cultured in 
the absence of T cells was 44-1,612 cpm. 
expression that is expressed on their surface.  Dendritic cells 
express from 10- to  100-fold more DR, DQ,  DP on their 
surfaces than B cells or monocytes. Thus, dendritic cells would 
have a major advantage in binding  or presenting  superan- 
tigens to T  cells  since they:  (a)  would quantitatively bind 
more superantigen,  and (b) express all three class II isotypes 
at  high  densities. 
However, it appears that  only a few of the Ia molecules 
on dendritic cells are utilized for presentation of superantigen. 
Dendritic cells pulsed for only 1 h  with  10-100 ng/ml  of 
SEB are as efficient as those exposed to the same concentra- 
tions of SEB continuously in culture for 3 d (Table 2). We 
find that  pulsing dendritic cells with these picomolar con- 
centrations of SEB leads to rapid and extensive clustering with 
T cells. Half-maximal proliferation of T cells is achieved after 
a pulsing dose of 1 ng/ml or 35 pM, whereas the published 
Kd for SEB, as determined on B cell lines,  is 1/zM (11). In 
fact, pulsing dendritic cells with 10 pg/ml (350 fM) still results 
in T  cell activation (Table 2). Furthermore,  since dendritic 
cells pulsed with picomolar concentrations of SEB can acti- 
vate T  cells when present  at  1 cell per  1,000 T  cells,  only 
trace numbers are necessary.  While other investigators have 
shown  that  superantigen-pulsed  APCs  stimulate  T  cells 
(23-25), in general, considerably higher doses have been used 
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(1 #g/ml).  In one other study, Ia + B cell lines were shown 
to present SEA to T  cells  after a  1-h pulse with  1 ng/ml, 
but graded doses of superantigen or APCs were not tested 
(15).  Our data suggest that for dendritic cells,  a very small 
fraction of MHC class II molecules need to be occupied to 
stimulate a T  cell.  In some respects, superantigen presenta- 
tion resembles peptide presentation where small amounts of 
antigen suffice and can saturate the system. Thus,  superan- 
tigen stimulation of T cells may be a useful and simple model 
to study the accessory functions  that  allow dendritic  cells 
to stimulate  so well. 
We have begun to assess the contribution of other mole- 
cules that are known to be involved in APC-T cell interac- 
tions.  Blood dendritic cells express high levels of two 13-2 
integrins  (LFA-1/CDlla and CD11c) and the adhesins leu- 
kocyte function-associated antigen 3 (LFA-3) and intercellular 
adhesion molecule 1 (ICAM-1) (13). Interaction of superan- 
tigens with Ia antigens on B cell lines leads to activation of 
LFA-1 molecules and more efficient homotypic aggregation 
of the calls (26).  ICAM-1 has recently been shown to pro- 
vide co-stimulator function for SEA-specific MHC class II--de- 
pendent activation of resting  CD4 + T  cells  (27).  Further- 
more, dendritic ceils express B7/BB1, the receptor for CD28, 
and these antigens are important participants in T  cell acti- vation and the generation  of the allogeneic MLR by den- 
dritic cells (Young, J. W., K. Koulova, S. A. Soergel, E. A. 
Clark,  R.  M.  Steinman,  and B. Dupont,  manuscript  sub- 
mitted for publication).  Thus, it is possible that the abun- 
dant expression of Ia antigens on dendritic cells is not the 
only feature that permits them to bind and present superan- 
tigens at low concentrations or trace numbers in vitro, Con- 
sistent with this interpretation,  we and others (5,  19) have 
shown that B cells, which express a higher degree of Ia an- 
tigens on their surfaces  than do monocytes (Fig. 3), appear 
to be less efficient than monocytes in superantigen presenta- 
tion.  Furthermore,  when B cells  are pulsed with as much 
as 1 #g/ml of SEB, they are nonstimulatory even at stimu- 
lator/responder ratios of 1:30 (data not shown). Superantigens 
have profound effects when given in vivo. Neonatal mice given 
SEB delete Vfl3 + and Vfl8 + T  cells (28). Injection of SEB 
into mice results in expansion followed by clonal anergy and 
a partial  deletion  of Vfl8.1 + CD4 + T  cells  (29).  Patients 
suffering from toxic shock syndrome have elevated levels of 
Vfl2 + T  cells (30).  Massive stimulation of these T  cells in 
vivo leads to the release of mediators such as TNF and IL-2, 
which may be responsible for inducing shock-like syndromes 
after infection (31). Likewise, APCs are stimulated to secrete 
IL-1 and TNF after stimulation with superantigens, and this 
compounds the clinical disease (32, 33). Because of the need 
for low levels of superantigen,  our findings raise  the possi- 
bility that dendritic cells are important APCs during inac- 
tion by organisms that generate superantigens. Dendritic cells 
can  stimulate  T  cells  in  a  V/g-selective  manner  (data  not 
shown), and they and their counterparts have been identified 
in blood, gut, skin, heart, and joint effusions (34-38). These 
are all organ systems involved in diseases  that  are likely to 
be caused by microbial superantigens. Furthermore, dendritic 
cells are known to migrate from tissues to lymph and blood, 
and then lymph nodes and spleen where presentation  to T 
cells would occur (39).  For limiting  or subsaturating con- 
centrations of superantigen,  dendritic cells are likely to be 
the first avenue whereby these proteins are encountered in 
the body. In recent studies in mice, dendritic cells have been 
shown to present the endogenous superantigens (Mls) in vivo 
(40). Given these findings, it is possible that very low levels 
of superantigens can stimulate T  cells and cause inflamma- 
tion  and tissue damage in  situ. 
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